VWA
CDTX

Visionary Wealth Advisors’s Cidara Therapeutics CDTX Stock Holding History

Visionary Wealth Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-650
Closed -$16.5K – 466
2023
Q1 		$16.5K Buy
+650
New +$18.4K ﹤0.01% 453

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Visionary Wealth Advisors's CDTX Position: Q2 2023 in Review

Visionary Wealth Advisors sold out of Cidara Therapeutics (CDTX) in Q2 2023, closing a stake of 650 shares — an estimated $16.5K sold.

Visionary Wealth Advisors first reported a position in CDTX in Q1 2023 and held it in 1 quarter. The position peaked at $16.5K in Q1 2023. 52 funds tracked by Wall St. Rank hold CDTX as of Q2 2023.

  • Visionary Wealth Advisors reported no remaining Cidara Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Visionary Wealth Advisors sold 650 Cidara Therapeutics shares in Q2 2023, an estimated $16.5K.
  • Visionary Wealth Advisors first reported a position in Cidara Therapeutics in Q1 2023 and held it in 1 quarter.
  • Visionary Wealth Advisors's Cidara Therapeutics position peaked at $16.5K in Q1 2023.
  • 52 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2023.

Based on Visionary Wealth Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.